Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-40,634
Closed -$1.14M 2456
2016
Q4
$1.14M Buy
40,634
+30,681
+308% +$859K 0.01% 1094
2016
Q3
$273K Sell
9,953
-32,270
-76% -$885K ﹤0.01% 1649
2016
Q2
$921K Sell
42,223
-29,977
-42% -$654K 0.01% 1214
2016
Q1
$1.61M Buy
+72,200
New +$1.61M 0.03% 586
2014
Q4
Sell
-53,853
Closed -$1.23M 1608
2014
Q3
$1.23M Buy
+53,853
New +$1.23M 0.06% 305

Other funds holding QGENF

Paloma Partners's QGENF Position: Q1 2017 in Review

Paloma Partners sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 40,634 shares — an estimated $1.14M sold.

Paloma Partners first reported a position in QGENF in Q3 2014 and held it in 5 quarters. The position peaked at $1.61M in Q1 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Paloma Partners reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Paloma Partners sold 40,634 QIAGEN NV shares in Q1 2017, an estimated $1.14M.
  • Paloma Partners first reported a position in QIAGEN NV in Q3 2014 and held it in 5 quarters.
  • Paloma Partners's QIAGEN NV position peaked at $1.61M in Q1 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Paloma Partners's 13F filing for Q1 2017, filed 15 May 2017.